Stock LUPIN LUPIN LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Lupin Limited

Equities

LUPIN

INE326A01037

Market Closed - Bombay S.E.
Other stock markets
 00:06:42 2024-05-07 EDT 		5-day change 1st Jan Change
1,635 INR -2.65% Intraday chart for Lupin Limited -0.45% +23.81%
05-06 Indian drugmaker Lupin misses quarterly profit estimates as costs rise RE
05-06 Lupin Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
RE
Lupin : May 6, 2024 Lupin Receives Approval from U.S. FDA for Travoprost Ophthalmic Solution USP
PU
Lupin Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Lupin Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Lupin : May 3, 2024 Lupin Launches Rymti® Biosimilar Etanercept in Canada
PU
Lupin Limited Receives an Order from Office of the State Tax Inspector, Jurisdiction: Ghatak 56: Range - 14: Division - 6: Gujarat
CI
Lupin : April 25, 2024 Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Suspension, 0.5%
PU
Lupin : April 25, 2024 Lupin Digital Health’s Lyfe Platform Receives Class C Medical Device License from CDSCO
PU
Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility
MT
Lupin : April 23, 2024 Lupin Receives EIR from U.S. FDA for its Aurangabad Manufacturing Facility
PU
Lupin : April 22, 2024 Lupin Launches Mirabegron Extended-Release Tablets in the United States
PU
INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains
RE
Lupin Launches Mirabegron Extended-Release Tablets in US
MT
Lupin Limited Announces Launch of Mirabegron Extended-Release Tablets, 25 Mg, in the United States, After Having Received an Approval from the United States Food and Drug Administration
CI
Lupin : April 12, 2024 U.S. FDA Completes Inspection of Lupin’s Dabhasa Facility with No Observations
PU
US FDA Clears Lupin's API Plant in Gujarat, India, Following GMP Inspection
MT
Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US
MT
Lupin : April 9, 2024 Lupin Launches First Generic Version of Oracea® (Doxycycline Capsules) in the United States
PU
Lupin Launches Generic Drug for Inflammatory Lesions of Rosacea in US
MT
Lupin Limited Announces the Launch of First Generic Version of Oracea® (Doxycycline Capsules, 40 Mg), in the United States
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LUPIN Stock
  4. News Lupin Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW